Study: Use of PET and PET/CT is cost-effective for some cancers

03/31/2010 | HealthImaging.com

German researchers who examined data from Germany, Britain, other European countries and the U.S. found that on a patient basis, the costs for PET and PET/CT procedures are decreasing with the increase in use of the procedures for certain cancers, including nonsmall-cell lung cancer, Hodgkin's disease, non-Hodgkin's lymphoma and colorectal carcinoma. There still is a need for larger trials to determine the cost-effectiveness of the tests for other cancers, the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC